Your cart is empty

Copper Peptide Research Compound
GHK-Cu is a copper-binding peptide widely examined for its role in cellular repair signaling and tissue remodeling processes in laboratory studies. Research often focuses on its influence on collagen-related activity, skin-associated pathways, and overall regenerative mechanisms within controlled experimental settings.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
GHK-Cu is a synthetic copper-binding tripeptide composed of glycine, histidine, and lysine complexed with copper ions. It is developed for controlled laboratory research involving peptide–metal interaction systems.
In scientific literature, GHK-Cu is studied in experimental models examining extracellular matrix signaling pathways, cellular communication frameworks, and tissue-related regulatory mechanisms under in vitro and preclinical research conditions.
Third-party tested for purity, identity, quantity.
GHK-Cu was first identified in the 1970s as a naturally occurring copper-binding peptide. Research has examined its interaction with extracellular matrix components, metalloproteinase signaling systems, and cellular regulatory pathways within controlled laboratory environments.
Experimental studies evaluate peptide–metal complex dynamics and pathway-level signaling frameworks under in vitro and preclinical research conditions.
The tripeptide GHK was originally isolated from human plasma and later identified as a copper-binding complex. Early investigations explored its biochemical properties and signaling interactions, leading to expanded research into extracellular matrix regulation and peptide-mediated cellular communication.
Over time, GHK-Cu became a widely studied peptide–metal complex within structural and signaling research models.
Laboratory investigations into GHK-Cu have focused on extracellular matrix interaction models, metalloproteinase-related pathways, and peptide–metal complex signaling systems. Research frameworks evaluate copper-binding dynamics and cellular regulatory mechanisms under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 120mg of lyophilized GHK-Cu. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.
PubMedIn vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest 92(5):2368–2376.
PubMedGHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.
PubMedRelated

Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00

Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00

Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00

GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00